Dictionary of Pharmaceutical Medicine

This dictionary defines various terms typically used in pharmaceutical medicine. A new, 4th edition includes adaptations of the text to the steadily increasing regulatory requirements, particularly in the area of genetics/gene therapy, product quality (e.g., protection against falsified medicines) a...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Nahler, Gerhard (Συγγραφέας)
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
Έκδοση:4th ed. 2017.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02313nam a22004575i 4500
001 978-3-319-50669-2
003 DE-He213
005 20170317144716.0
007 cr nn 008mamaa
008 170317s2017 gw | s |||| 0|eng d
020 |a 9783319506692  |9 978-3-319-50669-2 
024 7 |a 10.1007/978-3-319-50669-2  |2 doi 
040 |d GrThAP 
050 4 |a RS380 
050 4 |a RS190-210 
072 7 |a TDCW  |2 bicssc 
072 7 |a MED072000  |2 bisacsh 
082 0 4 |a 615.19  |2 23 
100 1 |a Nahler, Gerhard.  |e author. 
245 1 0 |a Dictionary of Pharmaceutical Medicine  |h [electronic resource] /  |c by Gerhard Nahler. 
250 |a 4th ed. 2017. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a X, 396 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Dictionary of pharmaceutical medicine -- Abbreviations/acronyms -- Selected bibliography -- Useful websites. 
520 |a This dictionary defines various terms typically used in pharmaceutical medicine. A new, 4th edition includes adaptations of the text to the steadily increasing regulatory requirements, particularly in the area of genetics/gene therapy, product quality (e.g., protection against falsified medicines) and of product safety (pharmacovigilance). Further evolving areas that are covered by the 4th edition are typical “grey zones” (health effects often borderline to medicinal products) such as cosmetics and dietary supplements where misleading information is prohibited on one hand but where any health claims need formal authorisation on the other. These but also other areas are reviewed and presented in an updated and – if justified – in an enlarged form. 
650 0 |a Medicine. 
650 0 |a Pharmacy. 
650 0 |a Pharmaceutical technology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Pharmaceutical Sciences/Technology. 
650 2 4 |a Pharmacy. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319506685 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-50669-2  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)